论文部分内容阅读
目的观察依达拉奉联合高压氧治疗脑梗死的疗效。方法将我院138例急性脑梗死患者随机分成对照组60例及治疗组78例二组:对照组采用常规综合救治及依达拉奉30mg,静滴,2次/d,疗程14d;治疗组在对照组治疗基础上联合给予高压氧治疗,14d后评定疗效。结果治疗组和对照组的有效率分别是88.47%和73.33%,治疗组与对照组比较,差异有统计学意义。结论依达拉奉联合高压氧治疗脑梗死有明显效果,值得推广。
Objective To observe the curative effect of edaravone combined with hyperbaric oxygen on cerebral infarction. Methods A total of 138 patients with acute cerebral infarction in our hospital were randomly divided into control group (60 cases) and treatment group (78 cases). The control group was treated with conventional comprehensive treatment and edaravone 30 mg intravenously for 2 times a day for 14 days. The treatment group In the control group based on the combination of hyperbaric oxygen therapy, 14d after the assessment of efficacy. Results The effective rates of the treatment group and the control group were 88.47% and 73.33% respectively. The difference between the treatment group and the control group was statistically significant. Conclusion Edaravone combined with hyperbaric oxygen treatment of cerebral infarction has obvious effect, it is worth promoting.